Category Archives: Medical

PaxVax obtains up to $62 million in financing


PaxVax, Inc., a biodefense and travel vaccine company, announced on Monday that it secured up to $62 million in financing as part of its acquisition of an oral typhoid vaccine. PaxVax acquired Vivotif, a U.S. Food and Drug Administration-approved oral … Read More »

Experts disagree on use of experimental ebola treatments


Health experts recently expressed disagreement regarding how to combat the ongoing ebola virus outbreak in West Africa. International response teams called for the use of experimental drugs or vaccines to stop the spread of the disease, which has infected 844 … Read More »

BARDA enters into public-private antibiotic development partnerships


The Biomedical Advanced Research and Development Authority (BARDA) recently established multiple private-public partnerships with industry to develop antibiotics. BARDA’s Broad Spectrum Antimicrobial programs, which grew from one partnership in 2010 to six in 2014, provide reimbursement to private partners in … Read More »

Engineered red blood cells could carry drugs, vaccines

Blood Cells

Scientists supported by the Defense Advanced Research Projects Agency recently modified red blood cells to carry payloads like drugs and vaccines, according to research published in the Proceedings of the National Academy of Sciences. The researchers from the Whitehead Institute … Read More »

VA solicits proposals for decontamination trailer

Veterans Affairs

The U.S. Department of Veterans Affairs issued a solicitation on Wednesday to build a patient decontamination trailer for the VA Greater Los Angeles Healthcare System. The trailer will allow the VA to protect patients, staff and facilities from terrorist attacks … Read More »

Soligenix announces combination ricin, anthrax vaccine


Soligenix, Inc., a clinical-stage biopharmaceutical company, announced on Wednesday that its combination ricin and anthrax vaccine induces protective immunity to both ricin toxin and anthrax toxin exposure. Soligenix, which conducted the studies under a $9.4 million cooperative grant from the … Read More »

Cytori receives notice of intent to exercise BARDA contract option


Cytori Therapeutics, a pharmaceutical company developing cell therapies to treat medical conditions, announced on Monday that it received notice of intent to exercise the first option of its contract with the U.S. government. The preliminary written notice of intent is … Read More »

Tekmira’s TKM-Ebola Phase I trial placed on clinical hold


Tekmira Pharmaceuticals Corporation, a developer of RNA interference (RNAi) therapeutics, announced on Thursday that a trial for its anti-Ebola virus therapeutic has been placed on clinical hold. The TKM-Ebola Phase I clinical trial is a randomized, single-blind, placebo-controlled study and … Read More »

U.S. nuclear medical countermeasure example could serve as example

Nuclear symbol

Despite recent advances in medical countermeasures to the possibility of a nuclear attack, the world health system is still unprepared for the potential use of a thermonuclear weapon. The U.S. medical countermeasure system could be used as an example for … Read More »

Data confirms mustard gas countermeasure efficacy


Biotechnology company Aeolus Pharmaceuticals, Inc., released data on Tuesday confirming the efficacy of a mustard gas medical countermeasure. The data, gathered from studies funded by the CounterACT Program, the National Institutes of Health Office of the Director and the National … Read More »

CureVac signs agreement with Sanofi to develop prophylactic vaccine


CureVac, a clinical-stage biopharmaceutical company, announced on Tuesday that it signed an exclusive license agreement with Sanofi Pasteur, S.A., to develop and commercialize an mRNA-based vaccine against an undisclosed pathogen. The agreement was the result of a successful multi-year collaboration … Read More »

BARDA changes deadlines for medical countermeasure applications


The Department of Health and Human Services (HHS) recently published amendments that modified the cycle dates for white paper submissions relating to medical countermeasures. The changes were intended to ensure that review dates occur quarterly and are aligned with all … Read More »

Security Consultant Jackson analyzes EU medical response strategy


Defense consultant Stephen Jackson outlined the EU’s strategy for preparing medical CBRN countermeasures on Monday in an editorial. Jackson detailed the EU’s framework for addressing health-related CBRN issues, which the Health Security Committee serves as the key mechanism for. The … Read More »

FICEMS establishes new five-year strategy to improve national EMS procedures

Federal Interagency Committee on Emergency Medical Services

The Federal Interagency Committee on Emergency Medical Services recently reached a consensus on the organization’s direction for the next five years, including 30 new objectives to enhance national EMS initiatives. FICEMS members said that during their biannual meeting in Washington, … Read More »

BioCryst completes successful animal trial of filovirus vaccine

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc., announced on Monday that its BCX4430 vaccine against filoviruses showed activity against a range of pathogens, including the Marburg and Ebola viruses, in an animal study. BioCryst is developing the vaccine under a contract with the National … Read More »